StockData
IRIXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends January 3

IRIDEX CORP

Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Aug 18, 2026
$0.77−0.04 (-5.48%)

Close on Oct 19, 2026

Market cap
$13.41M
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 11, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jul 4, 2026
Aug 18, 2026After market close$12.60M$-0.07–
Q1 FY2026
Ended Apr 4, 2026
May 19, 2026After market close$11.80M$-0.03–
Q4 FY2025
Ended Jan 3, 2026
Jan 12, 2026Before market open–––
Q3 FY2025
Ended Sep 27, 2025
Nov 12, 2025After market close$12.50M$-0.09–
Q2 FY2025
Ended Jun 28, 2025
Aug 12, 2025After market close$13.60M$-0.06–
Q1 FY2025
Ended Mar 29, 2025
Apr 14, 2025After market close–––
Q4 FY2024
Ended Dec 28, 2024
Jan 14, 2025During market hours–––
Q3 FY2024
Ended Sep 28, 2024
Nov 12, 2024After market close$11.60M––
Q2 FY2024
Ended Jun 29, 2024
Aug 8, 2024After market close–––
Q1 FY2024
Ended Mar 30, 2024
May 14, 2024After market close–––
Q3 FY2023
Ended Sep 30, 2023
Nov 14, 2023After market close–––

Company guidance

Outlook given with results on Aug 18, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
adjusted operating expensesnon-GAAPfiscal year 2026$19.00M to $19.50MMaintained
annual revenuefull year 2026$51.00M to $53.00MMaintained

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Iridex filed with the SEC